Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Proot
Baseline Characteristics in the VERIFY Study: A Randomized Trial Assessing the Durability of Glycaemic Control With Early Vildagliptin-Metformin Combination in Newly Diagnosed Type 2 Diabetes
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
A Prospective Randomized Study: Role of Enalapril on Oxidative Stress in Newly Diagnosed Type 2 Diabetes Mellitus and Its Correlation With Glycaemic Status
International Journal of Basic & Clinical Pharmacology
A Prospective Open Labelled Study of Effect of Vildagliptin With Metformin in Patients With Type 2 Diabetes Mellitus
International Journal of Basic & Clinical Pharmacology
Early Glycaemic Control in Metformin Users Receiving Their First Add-On Therapy: A Population-Based Study of 4,734 People With Type 2 Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients
IOSR Journal of Dental and Medical Sciences
A Retrospective Comparison Study Between the Effectiveness and Safety of Fixed Dose Combination of Vildagliptin Versus Sitagliptin With Metformin in Type 2 Diabetes Mellitus Patients
Indian Journal of Pharmacy Practice
Use of Metformin and Vildagliptin for Treatment of Type 2 Diabetes in the Elderly
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
A Variant of the Glucose Transporter Gene SLC2A2 Modifies the Glycaemic Response to Metformin Therapy in Recently Diagnosed Type 2 Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Vildagliptin: Optimal Control in Type 2 Diabetes Mellitus Treatment
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes